Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced that the Company will release its third quarter 2021 financial results on Friday, November 12, 2021, before the U.S. financial markets open.
October 26, 2021
· 2 min read